Kagenori Ito

8PUBLICATIONS
15CO-AUTHORS
Haematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 10, 2026
Perioperative Safety and Long-Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real-World Study of 668 Patients.

|Dec 30, 2025
Significance of EVs in Prostate Cancer Bone Metastases.

Kagenori Ito, Takaaki Tamura, Fumihiko Urabe

|Mar 04, 2025
Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives.

Kentaro Yoshihara, Kagenori Ito, Takahiro Kimura

|Jun 20, 2020
The miR-1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer.

Fumihiko Urabe, Nobuyoshi Kosaka, Yurika Sawa

|Jun 05, 2020
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1.

Fumihiko Urabe, Nobuyoshi Kosaka, Yurika Sawa

|Apr 05, 2020
CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells.

Junichiro Chikuda, Kurataka Otsuka, Iwao Shimomura

Pageof 2

Frequent Collaborators

4 joint publications

Takahiro Kimura

4 joint publications

Fumihiko Urabe

2 joint publications

Yusuke Yamamoto

2 joint publications

Nobuyoshi Kosaka